Creative Peptides Intelligence Profile
Research Incomplete
Research coverage for this vendor is 71%. Our research on Creative Peptides remains incomplete — what we have verified so far is published below, and research is continuing.
Still to research:
- Research coverage ≥ 80%
- Legal entity researched (legal_entity_name)
- Registration jurisdiction researched (state_of_registration)
- Entity status researched (entity_status)
- Refund policy reviewed (refund_return_policy)
- Payment methods reviewed (accepted_payment_methods)
- Public summary reviewed
Overview#
Creative Peptides is a New York (Shirley, NY 11967) B2B peptide CDMO / custom-synthesis company at creative-peptides.com — FIT confirmed: it sells catalog peptides/APIs and extensive custom synthesis, modification, conjugation, library and GMP-manufacturing services for research, drug-discovery, clinical-development and cosmetic customers, on an inquiry/quote model with no retail checkout and products framed for research/industrial use, not individual clinical/medical use. Domain registered 2008-07-14 (GoDaddy), site and press coverage continuous since at least 2016, current address SUITE 115, 17 Ramsey Road, Shirley, NY 11967, Tel 1-631-624-4882, info@creative-peptides.com. Corporate transparency is limited in a different way from RUO storefronts: the operating business is real and long-running, but no legal entity name, registration jurisdiction, entity status, formation date, registered agent or officer is published on the site, and the NY DOS portal could not be retrieved at intake, so identity fields are Unknown — NOT inferred from the co-located 'Creative' brand cluster at Ramsey Road (Creative Biolabs, Inc. is a separate brand at the same address and is not attributed as the parent/entity). All defined regulatory searches (FDA warning letters, recalls, import alerts, FTC, state AG, civil litigation, criminal/injunctive) returned No Record Found in the defined search; FDA 'Creative Essences' / 'Creative Science' letters are different companies. Testing disclosure is B2B-style: CoA/HPLC/MS/synthesis report are per-project deliverables, with no public per-lot COA library, no verification portal, and no named independent lab — QC and 'strict cGMP compliance' are vendor representations uncorroborated by any certification/registration document located. No payment methods, refund/return policy, or shipping policy are published (contractual B2B terms). No High/Critical findings.
Company Identity#
Domain and Digital Identity#
Regulatory and Legal History#
Testing and COA Evidence#
Payment, Refund and Shipping#
Material Changes#
No material changes recorded.